Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CLOFAZIMINE
- Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
- Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease
- A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
- Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial Disease
- A Study of Ultrashort PRS Regimen V in the Treatment of MDR-TB
- Phase II Study of a Nebulised Nitric Oxide Generating Solution in Patients With Cystic Fibrosis
- Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
- Linezolid Dosing Strategies in Drug-Resistant TB
- A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
- Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)
- Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
- Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
- Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
- Economic Evaluation of New MDR TB Regimens
- PRACTECAL-PKPD Sub Study
- Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
- Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB
- Pilot Clinical Trial of PRS TB Regimen I - Phase II
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
- A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
- Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
- Evaluating Newly Approved Drugs for Multidrug-resistant TB
- Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)
- Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
- Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)
- Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
- Effect of Additional Clofazimine on Erythema Nodosum Leprosum (ENL) Reactions in Leprosy
- Treatment Protocol for Clofazamine in the Long Term Treatment of Leprosy
- Uniform Multidrug Therapy Regimen for Leprosy Patients
- Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
- Montelukast in ENL Reaction
- Clarithromycin in Active Crohn's Disease
- The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
- A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease
- A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
- Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDR
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
Clinical trials list
click for details